Eric Malek is VP of Corporate Development at ALLOS THERAPEUTICS INC (ALTH). They have made 3 open-market trades across 1 company since 2005, most recently 2006-12-29.
CIK 0001327852
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $6K since 2005, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ALTH | 39,196 | — |
Shares reported on the most recent Form 4, priced at the 2007-01-03 close. 1 holding could not be priced and is excluded from the total.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.